OTC Brimonidine (Lumify) for Ocular Redness
Date: October 22, 2018
Issue #:
1558Summary:
The FDA has approved an over-the-counter (OTC)
0.025% ophthalmic formulation of the selective
alpha2-adrenergic agonist brimonidine tartrate (Lumify– Bausch& Lomb) for treatment of ocular redness in
adults and children≥5 years old. Lumify is the first
brimonidine product to be approved for OTC use.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Alphagan Beta blockers brimonidine brimonidine/timolol Combigan Eye Lumify Oxymetazoline Source Type: research